Literature DB >> 575331

E.O.R.T.C. phase II study of cisplatin in cyvadic-resistant soft tissue sarcoma.

V H Bramwell, A Brugarolas, H T Mouridsen, F Cheix, F De Jager, A T van Oosterom, C P Vendrik, H M Pinedo, R Sylvester, M De Pauw.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 575331     DOI： 10.1016/0014-2964(79)90032-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  3 in total

1.  [Chemotherapy of soft tissue sarcomas].

Authors:  D K Hossfeld; S Seeber; E Siemers; C G Schmidt
Journal:  Langenbecks Arch Chir       Date:  1981

2.  High-dose adriamycin (ADM) and cis-platinum (DDP) in advanced soft-tissue sarcomas and invasive thymomas. A pilot study.

Authors:  T H Klippstein; P S Mitrou; K J Kochendörfer; L Bergmann
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

3.  Efficacy of ifosfamide, dacarbazine, doxorubicin and cisplatin in human sarcoma xenografts.

Authors:  W Budach; V Budach; M Stuschke; B Schmauder; P Reipke; M E Scheulen
Journal:  Br J Cancer       Date:  1994-07       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.